Renal function after bladder‐preserving therapy for patients with muscle‐invasive bladder cancer: Results of selective bladder‐preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cystectomy

Editorial Comment from Dr Kojima to Renal function after bladder‐preserving therapy for patients with muscle‐invasive bladder cancer: Results of selective bladder‐preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cystectomy

“…In their article published in the International Journal of Urology, Toide et al reported after tetramodality therapy consisting of TMT plus partial cystectomy, renal function was relatively well preserved over time, and did not appear to be inferior to that after RC or TMT. 4 This is the first study to report the time course of renal function after bladder-preserving therapy.…”

Editorial Comment from Dr Kobayashi to Renal function after bladder‐preserving therapy for patients with muscle‐invasive bladder cancer: Results of selective bladder‐preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cystectomy

“…In a Urological Note in this issue, Toide et al . reported the renal function outcome after their selective bladder‐preserving tetramodality therapy . This group of authors first reported this treatment strategy in 2012 (reference 3 in the Urological Note ), and further published the long‐term, larger‐scale outcome in 2019 (reference 4 in the Urological Note ).…”